Please ensure Javascript is enabled for purposes of website accessibility

Why Healthequity Rose 15.1% On Friday

By Brian Feroldi - Updated Mar 14, 2020 at 11:54AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The beaten-down growth stock ended a tough week on the upswing.

What happened

Shares of Healthequity (HQY 3.62%), a leading administrator of health savings accounts, jumped 15.1% on Friday. There doesn't appear to be any company news that could justify the double-digit boost. That makes it likely that the stock is simply rebounding from its recent sell-off, along with the rest of the market.

It also didn't hurt that the Dow Jones Industrial Average, S&P 500, and Nasdaq all rose more than 9% on Friday.

So what

Lots of growth stocks have been sold off very hard during the last few weeks in response to the growing concerns of the spread of COVID-19. Healthequity was no exception. As of Thursday, Healthequity's stock was down more than 45% from its February highs, which is a stunning move in such a short period of time.

Piggybank with the letters hsa written on the side

Image source: Getty Images.

Amazingly, there hasn't been any news out of the company during that time that could justify such a massive drop. In fact, the last time the company issued market-moving news was when it reported its year-end fiscal 2020 sales metrics, which looked great. Management even revised its full-year revenue and profit guidance upward when it released its numbers, which caused Wall Street to cheer. 

However, that good news hasn't come close to offsetting the enormous marketwide selling pressure that has cropped up in the last few weeks. With the Dow Jones Industrial Average, S&P 500, and Nasdaq all dropping into bear market territory this week, it makes sense that Healthequity's stock has also been in freefall.

Now what

Healthequity is set to report its fourth quarter and full-year fiscal 2020 earnings on Monday, March 16. Management had previously indicated that they expect to generate between $812 million and $820 million in sales during fiscal 2021, which represents growth of about 53% at the midpoint. Shareholders will want to tune in to see if the coronavirus fallout will cause them to revisit that number.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

HealthEquity, Inc. Stock Quote
HealthEquity, Inc.
$60.96 (3.62%) $2.13

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/07/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.